Yahoo
Frankfurt - Delayed Quote EUR

Zevra Therapeutics, Inc. (1GDA.F)

9.18 +0.10 (+1.10%)
As of 3:42:59 PM GMT+1. Market Open.
1GDA.F Q3 2026 earnings call
November 3, 2026 at 10:30 PM GMT+1
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
136,071
106,470
23,612
27,461
10,161
Cost of Revenue
6,180
16,482
7,417
2,173
222
Gross Profit
129,891
89,988
16,195
25,288
9,939
Operating Expense
90,824
94,221
103,198
74,892
34,841
Operating Income
39,067
-4,233
-87,003
-49,604
-24,902
Net Non Operating Interest Income Expense
4,470
-1,031
-5,176
3,040
1,178
Other Income Expense
25,751
91,942
2,039
515
-3,081
Pretax Income
69,288
86,678
-90,140
-46,049
-26,805
Tax Provision
11,025
3,449
15,371
0
-33
Net Income Common Stockholders
58,263
83,229
-105,511
-46,049
-26,772
Diluted NI Available to Com Stockholders
58,263
83,229
-105,511
-46,049
-26,772
Basic EPS
0.96
1.35
-2.28
-1.30
-1.20
Diluted EPS
0.93
1.35
-2.28
-1.30
-1.20
Basic Average Shares
57,482.78
55,311.31
46,251.24
35,452.46
34,488.80
Diluted Average Shares
59,624.31
57,262.72
46,251.24
35,452.46
34,488.80
Total Operating Income as Reported
82,381
-62,943
-87,003
-49,604
-42,565
Total Expenses
97,004
110,703
110,615
77,065
35,063
Net Income from Continuing & Discontinued Operation
58,263
83,229
-105,511
-46,049
-26,772
Normalized Income
36,609.46
-5,053.71
-107,027.40
-46,564
-23,694.70
Interest Income
10,180
6,946
2,175
4,541
1,513
Interest Expense
5,710
7,977
7,351
1,501
335
Net Interest Income
4,470
-1,031
-5,176
3,040
1,178
EBIT
74,998
94,655
-82,789
-44,548
-26,470
EBITDA
76,484
98,709
-76,400
-43,542
-25,526
Reconciled Cost of Revenue
5,957
16,290
7,263
1,939
222
Reconciled Depreciation
1,486
4,054
6,389
1,006
944
Net Income from Continuing Operation Net Minority Interest
58,263
83,229
-105,511
-46,049
-26,772
Total Unusual Items Excluding Goodwill
25,751
91,942
2,039
515
-3,081
Total Unusual Items
25,751
91,942
2,039
515
-3,081
Normalized EBITDA
50,733
6,767
-78,439
-44,057
-22,445
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,097.46
3,659.29
522.60
0
-3.70
12/31/2022 - 6/22/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: